---
title: "Why top 3% biotech stock, Eton, just catapulted to a record high"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295950325.md"
description: "Eton stock catapulted to a record high Friday after the biotech company smashed second-quarter sales forecasts and hiked its guidance."
datetime: "2026-08-14T14:52:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295950325.md)
  - [en](https://longbridge.com/en/news/295950325.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295950325.md)
generator: "portal-rs"
---

# Why top 3% biotech stock, Eton, just catapulted to a record high

Eton stock catapulted to a record high Friday after the biotech company smashed second-quarter sales forecasts and hiked its guidance.

### Related Stocks

- [ETON.US](https://longbridge.com/en/quote/ETON.US.md)

## Related News & Research

- [PAUL MAIER V At Eton Pharmaceuticals Executes Options Exercise, Realizing $2.84M](https://longbridge.com/en/news/297670548.md)
- [Eton Pharmaceuticals (ETON) Faces A Valuation Test Following Its Rare Disease Growth Narrative](https://longbridge.com/en/news/297622328.md)
- [Eton Pharmaceuticals Director Sold Shares Worth Over $2.9M](https://longbridge.com/en/news/297369093.md)
- [Eton Pharma director Paul V. Maier reports disposal of common shares worth $2.94 million](https://longbridge.com/en/news/297368108.md)
- [Polaryx Therapeutics names Dr. Will Charlton as CMO ahead of Q4 2026 SOTERIA Phase 2 start](https://longbridge.com/en/news/297697446.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**